Dr. Mohammad Rafiqul Mowla received his MBBS, MD, PhD degrees from the Chittagong University of Bangladesh. He serves as Associate Professor in the Department of Dermatology and Venereology at Chittagong Medical College, Bangladesh, where he directs the department’s research section and mentors post-doc, graduate and undergraduate students. Currently, he is heading efforts in his department to initiate clinical trials in patients with autoimmune and inflammatory skin diseases to test drugs that were developed largely based on preclinical and translational research. Dr. Mowla received the Global Education Award from the International Society of Dermatology, the Strauss & Katz Award from the American Academy of Dermatology, and the World Congress of Dermatology 2015 and 2019 Scholarship Award from the International League of Dermatological Societies. He is an author of many publications in national and international scientific journals, original articles, clinical and scientific research studies, epidemiological reports and abstracts presented at national and international congresses. He has co-authored many scientific publications in reputed peer reviewed journals (JAAD, JEADV, IJD, Lupus, CDJ, STI, CED, SHD, Dermatologic Therapy, Forum Dermatologicum, GJDV, JCMTA and BJDVL etc.) and has been serving as an editorial board member in three national and international journals. Dr. Mowla is passionate about the Internet and its use for diagnostic teledermatology, medical education, and consumer health information. He is excited about the promise of artificial intelligence in widening access to dermatological expertise. Dr. Mowla is also active in a number of highly regarded national and international medical groups. Currently, he is one of the Directors of International Society of Dermatology (ISD). He is a Member of the International Affairs Committee (IAC) of American Academy of Dermatology (AAD) and Member, ERG ‘Climate Change’ of AAD. He was an Ambassador of ICD 2021, Melbourne.